Market Tracker

01/27 9:08am ET

Immunomedics Inc (NASDAQ:IMMU)

Monday’s Trading Day
4.89 +0.16 / +3.38%
Data as of Jan 26
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
4.87 -0.02 / -0.41%
 
Volume: 1.0K

Today’s Trading

Previous close4.73
Today’s open4.73
Day’s range-- - --
Volume464,829
Average volume (3 months)703,515
Market cap$455.4M
Dividend yield--
Data as of 01/26/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-19.05%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales44.93
Price/Book11.57

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.08-0.54%
ARDXArdelyx Inc-0.46-1.73%
CLDNCelladon Corp+0.74+4.35%
LMNSLumenis Ltd+0.95+9.89%
Data as of 01/26/2015

Financials

Next reporting dateFebruary 3, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts